NEW YORK (GenomeWeb News) – Seeking a share of a market estimated at around $1 billion, GenomeDx plans to launch its first test aimed at prostate cancer during the first half of this year, CEO Doug Dolginow said.
NEW YORK (GenomeWeb News) — Arizona State University's Biodesign Institute today announced a partnership with Life Technologies to develop a gene expression test to rapidly assess an individual's exposure to radiation in the event of a nuclear incident.
NEW YORK (GenomeWeb News) – National managed healthcare company WellPoint has revised its medical policy regarding non-invasive fetal aneuploidy screening, suggesting that it will begin covering tests such as Sequenom's MaterniT21 Plus test.
NEW YORK (GenomeWeb News) – Molecular diagnostics firm DioGenix today announced it has raised $1.5 million in a Series B financing round.
Existing investors including life sciences fund Nerveda participated in the round.
NEW YORK (GenomeWeb News) – Sequenom said Friday evening that it has received notification from the US Patent and Trademark Office that a patent that was scheduled to issue next week has been withdrawn.
NEW YORK (GenomeWeb News) – Microarrays can provide more clinically relevant information than traditional karyotyping, and should become the standard approach in prenatal diagnostics going forward, according to a paper appearing tod